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Background: Chromosome 12q24 was recently associated with hypertension. Proteasome Modulator 9 (PSMD9)
lies in the 12q24 locus and is in linkage with MODY3, type 2 diabetes (T2D), microvascular and macrovascular
pathology, carpal tunnel syndrome, and hypercholesterolemia in Italian families.
Aims: Our goal was to determine whether PSMD9 is linked to elevated blood pressure/hypertension in T2D
families.
Methods: We characterized the Italian T2D families’ members for presence and/or absence of elevated blood
pressure (≥ 130/80) and/or hypertension. The phenotypes were described as unknown in all cases in which the
diagnosis was either unclear or the data were not available for the subject studied. We tested in the 200 Italians
families for the presence of the linkage of the PSMD9 T2D risk single nucleotide polymorphisms (SNPs) IVS3+nt460
A>G , IVS3+nt437 T > C and E197G A > G with elevated blood pressure/hypertension. The non-parametric linkage
analysis was performed for this qualitative phenotype by using the Merlin software; the Lod score and
correspondent P-value were calculated. Parametric linkage analysis was also performed. For the significant linkage
score, 1000 replicates were run to calculate the empirical P-value.
Results: The PSMD9 gene SNPs studied are in linkage with elevated blood pressure/hypertension in our Italian
families.
Conclusions: We conclude that the PSMD9 gene and/or any variant in linkage disequilibrium with the SNPs
studied contribute to the linkage to hypertension within our family dataset. This is the first report of PSMD9 linkage
to hypertension within the 12q24 locus.
Introduction
A recent study has shown that changes in retinal vascular
caliber are linked to the chromosome 12q24 locus in a
large Caucasian population [1]. Microcirculation is impor-
tant in determination of hypertension [1] and retinal vascu-
lar changes reflect early microvascular disease and predict
cardiovascular events. In two independent samples, the
locus 12q24 was also associated with coronary heart dis-
ease and hypertension [1]. Thus, the chromosome 12q24
locus carries at least a gene contributing to hypertension.
In this locus lies Proteasome Modulator 9 (PSMD9), a
coactivator of insulin gene transcription, which is highly
expressed in pancreatic islets [2]. PSMD9 is a ubiquitous
protein; therefore its biological role may be broad. PSMD9
overexpression cause beta-cell dysfunction and contribute
to type 2 diabetes (T2D) [2]. We reported that PSMD9
may rarely cause T2D by unique mutations [3]. We identi-
fied a significant linkage of the PSMD9 A/T/G haplotype
to late-onset T2D, with the strongest evidence under the
recessive model [4], and to MODY3 under the additive
model [5] in Italians. The contribution of intronic variants
to complex disorders is an accepted concept. We recently
reported a linkage of the PSMD9 T2D risk single nucleo-
tide polymorphisms (SNPs) with T2D-nephropathy [6],
T2D-neuropathy [7], retinopathy [8], carpal tunnel syn-
drome [9], hypercholesterolemia [10], and macrovascular
pathology [11]. Given the reported linkage data of PSMD9
within the locus 12q24, and the evidence of linkage with
microcirculation within the same locus [1], PSMD9 is a
candidate gene for hypertension. Further, as PSMD9 is
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any medium, provided the original work is properly cited.linked to T2D, it should be screened to identify any inheri-
tance contributing factors to the T2D-associated pheno-
types, of which hypertension is a major player.
In the present study, we aimed at testing the PSMD9
IVS3+nt460, IVS3+nt437, E197G T2D risk SNPs for
linkage with elevated blood pressure and/or hyperten-
sion in our 200 Italian T2D families.
Methods
Ethical Statement
the subjects were all recruited from center Italy follow-
ing the Helsinki declarationg u i d e l i n e s .S u b j e c t sg a v e
written informed consent. The Penn State College of
Medicine Ethical Committee approved the study.
Families
We recruited 200 Italian T2D affected siblings and
extended families, including also unaffected members.
The families originate from the center of Italy. The
members are at least three generations Italians. Identi-
cal twins were excluded. These T2D families have been
helpful in the whole or as unrelated T2D cases in iden-
tifying or excluding diabetes risk genes and/or variants
in previous studies [12-24]. We characterized the Ita-
lian families for presence/absence of elevated blood
pressure/hypertension [presence is considered by blood
pressure ≥ 130/80 mmHg in drug-naïve patients or by
use of anti-hypertensive medication(s)]. Phenotype is
described as unknown if diagnosis is unclear or data
are lacking. Most subjects with T2D have elevated
blood pressure and few subjects without T2D have ele-
vated blood pressure. The total of the subjects avail-
able for the analysis including the ungenotyped parents
is 928 (443 founders, 485 non-founders; 467 females,
461 males) with an average family members of 4.62.
The diagnostics of hypertension is present in 373 gen-
otyped individuals, with a prevalence of 94.6%.
Sequencing
Via PCR, we amplified the IVS3 PSMD9 region contain-
ing the +nt460 A > G and +nt437 C > T SNPs and the
exon 5 coding region containing the E197G A > G SNP
with specific primers in the affected and unaffected
family members. We directly sequenced the PCR pro-
ducts, status post-purification via EXOSAP-IT, on an
automated ABI 3730 Sequencer.
Statistical Analysis
We tested in the 200 Italian families for linkage of the
PSMD9 SNPs with elevated blood pressure/hyperten-
sion. Both non-parametric and parametric linkage analy-
sis for the qualitative phenotype were performed for the
three SNPs via Merlin software [25]. Allele frequencies
were calculated from the data [25]. Merlin analysed all
genetically informative families (n = 129; total subjects =
596) within this dataset, depending on the presence of
both genotypes and hypertension phenotype in families
whose structure, given the data, was amenable to the
linkage tests. The families analysed by Merlin are repre-
sentative of the population. We previously reported that
the PSMD9 SNPs IVS3+nt460, IVS3+nt437, E197G are
in strong linkage disequilibrium (LD) [3]. The following
parameters were used for the parametric linkage analysis
based on the SNPs-cluster, thus eliminating the LD
inflation of the linkage signal: disease allele frequency
0.25, dominant model with penetrance for homozygous
non-risk allele 0.31 (equal to the prevalence of hyperten-
sion in the Italian population), for heterozygous risk
allele 1.00, for homozygous risk allele 1.00; recessive
model with penetrance for homozygous non-risk allele
0.31, for heterozygous risk allele 0.31, for homozygous
risk allele 1.00; additive model with penetrance for
homozygous non-risk allele 0.31, for heterozygous risk
allele 0.45 and for homozygous risk allele 0.90. All
results are reported as LOD scores calculated by Merlin.
For each test performed, to exclude the presence of any
false positive in our results, we calculated how many
times similar P-values were expected by chance in 1,000
replicates of simulations by using the gene dropping
m e t h o d :t h i sa n a l y s i sr e p l a c e sr e a ld a t aw i t hs i m u l a t e d
data, while maintaining the pedigree structure, allele fre-
quencies and recombination fraction. These datasets are
generated under the null hypothesis of no linkage.
Results
The results of the non-parametric and parametric linkage
analysis performed for the qualitative phenotype hyper-
tension are reported in table 1. Both analytical methods
have reported significant results with the most significant
being for the non-parametric model. The PSMD9 SNP
IVS3+nt460 is slightly more significant than the other
two SNPs. Under the parametric model analysis, the
most significant is the dominant model. The simulation
analyses of 1,000 replicates have excluded false positives
and establish the validity of the real data.
Discussion
Our analysis show that the P S M D 9I V S 3+ n t 4 6 0A>G
and +nt437 C > T and exon 5 E197G A > G SNPs studied
and/or any variants in LD with them are in linkage with
elevated blood pressure/hypertension in our 200 Italian
families. The PSMD9 SNPs studied contribute to the
linkage of the reported phenotype. It is possible that the
recessive and additive models appear less significant than
the dominant model, as the disease penetrance value
given for the heterozygous state under both models, and
f o rt h eh o m o z y g o u ss t a t eu n d e rt h ea d d i t i v em o d e l ,i s
inferior to 1. Thus, some of the power of the data may be
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are still significant as the variants in homozygous state
are likely inherited by the affected family subjects more
often than expected by the null hypothesis of no linkage
and thus contribute to the linkage signal. The limitation
of our study is that the linkage may capture the signal
from the potential co-inheritance of genetic variants
linked to another phenotype and to the underlying T2D
that is commonly shared with hypertension; however, as
T2D patients have high prevalence of hypertension, vir-
tually all linkage studies performed in T2D may as well
mask a linkage with hypertension. In fact, when we statis-
tically analyze only a single phenotype, we cannot protect
the results from any potentially known and unknown
associated factor with the phenotype under study and
from the co-inheritance of genetic variants related to that
factor underlying the linkage signal.
T h es t r e n g t ho fo u rs t u d yr e s i d e si nt h es i g n i f i c a n t
data both at the level of non-parametric analysis, which
is not vulnerable to miscalculation of allele frequencies
and penetrance values, as well as at the level of the
parametric analysis, which may suffer from not perfect
estimates of allele frequencies and penetrance values.
However, the best statistical power test is the simulation
empirical P-value, and in this study all empirical P-values
have excluded the possibility of false positives in our data
analysis.
These findings have not yet been confirmed in other
ethnicities.
Conclusions
The PSMD9 SNPs IVS3+nt460, IVS3+nt437, E197G are
significantly linked to elevated blood pressure/hyperten-
sion in the Italian T2D family dataset.
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